Head growth is one of the first features to fail to proceed with a normal velocity, and careful measurements can identify this as early as 2 months of life.21 A combination of decreased head growth velocity and developmental delay in girls is BYL719 supplier currently the most likely way that affected individuals are identified prior to regression. Gastrointestinal problems Nearly all affected

individuals have significant gastrointestinal problems. Motility and coordination are disrupted throughout the entire gastrointestinal tract, leading to chewing and swallowing problems, gastroesophageal reflux, delayed stomach emptying,22 bloating, Inhibitors,research,lifescience,medical and constipation.17 These gastrointestinal issues can have a significant impact on quality of life in affected people. Seizures and nonepileptic spells The majority of affected people have seizures during their lives; however a significant percentage (up to 40%) of people do not have seizures.23 Inhibitors,research,lifescience,medical This is somewhat surprising given the markedly abnormal electroencephalogram (EECj) present in all affected people.24 The EEG abnormalities include frequent multifocal epileptiform discharges, which can Inhibitors,research,lifescience,medical become nearly continuous during sleep, and slow background activity.24 A wide variety

of antiseizure medications have been used to control seizures in RTT, and no clinical trials have been performed to indicate improved efficacy with any particular agent. Some people have medically intractable epilepsy requiring either vagal nerve stimulator placement25 or ketogenic Inhibitors,research,lifescience,medical diet,26 both of which have some efficacy in RTT. In addition to epileptic seizures, people with RTT also commonly have nonepileptic paroxysmal events. The events are often associated with

breathing abnormalities and can clinically appear to be seizures, even to trained clinical observers. During these events, the patient may have tonic extension of limbs with a vacant look, often with breath-holding. Occasionally the nonepileptic paroxysms can Inhibitors,research,lifescience,medical include high-amplitude irregular movement of limbs more akin to a paroxysmal dyskinesia. The events are more common at sleep/wake transitions. Because the semiology of these events can be consistent with true epileptic events, it is important to consider evaluation with video EEG to confirm the epileptic nature of paroxysmal events in RTT. Unfortunately, no medical therapy has proven beneficial for treatment of these nonepileptic events in RTT. Breathing abnormalities Nearly all oxyclozanide people with RTT have some degree of breathing abnormalities. Commonly there is some degree of hyperventilation and/or apnea.27-29 The hyperventilation can be significant enough to cause hypocapnea, and some investigators have proposed treatment with gas mixtures containing increased concentrations of carbon dioxide.30 The apneic events can cause a decrease in blood oxygen and occasionally are prolonged to the point of loss of consciousness.